NM_000535.7:c.989-2A>G
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PVS1_StrongPP4_ModeratePM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000535.7: c.989-2A>G p.(?) variant in PMS2 occurs within the canonical splice acceptor site (-2) of intron 9. It is predicted to result in an in-frame exon 10 skipping and the altered region is critical to protein function (PVS1_Strong). RNA studies have confirmed that this variant causes the in-frame skipping of exon 10 (r.989_1144del), resulting in the deletion of the C-terminal ATPase domain (PMID:23709753, 26247049, 30306255). This variant has been detected in at least 2 independent CRC/Endometrial MSI-H tumours using a standard panel of 5-10 markers and/or loss of MMR protein expression consistent with the variant location. This variant is absent from gnomAD v2.1.1 and gnomAD v4.1 (PM2_supporting).In summary, this variant meets the criteria to be classified as likely pathogenic for Lynch-Syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/ Polyposis VCEP: PVS1_STR, PM2_SUP, PP4_MOD (VCEP specifications version 1) LINK:https://erepo.genome.network/evrepo/ui/classification/CA013438/MONDO:0013699/139
Frequency
Consequence
NM_000535.7 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | MANE Select | c.989-2A>G | splice_acceptor intron | N/A | NP_000526.2 | P54278-1 | |||
| PMS2 | c.1175-2A>G | splice_acceptor intron | N/A | NP_001393795.1 | A0A8V8TNX6 | ||||
| PMS2 | c.989-2A>G | splice_acceptor intron | N/A | NP_001308943.1 | A0A8V8TQ50 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | TSL:1 MANE Select | c.989-2A>G | splice_acceptor intron | N/A | ENSP00000265849.7 | P54278-1 | |||
| PMS2 | TSL:1 | c.804-6966A>G | intron | N/A | ENSP00000371758.4 | P54278-2 | |||
| PMS2 | TSL:1 | n.989-2A>G | splice_acceptor intron | N/A | ENSP00000514464.1 | P54278-3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1426258Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 710354
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at